Medicare Enrolled

Dr. Christopher Inhulsen, M.D.

Family Medicine · Oglethorpe, GA
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
Low-engagement
300 MEDICAL COURT, Oglethorpe, GA 31068
4784589942
In practice since 2006 (20 years)
NPI: 1396788592 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Inhulsen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Inhulsen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Inhulsen

Dr. Christopher Inhulsen is a family medicine specialist in Oglethorpe, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Inhulsen performed 527 Medicare services across 232 unique beneficiaries.

Between the years covered by Open Payments, Dr. Inhulsen received a total of $3,648 from 27 pharmaceutical and/or device companies across 219 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Inhulsen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 527 Medicare services $3,648 industry payments

Medicare Practice Summary

Medicare Utilization ↗
527
Medicare services
Bottom 44% in GA for family medicine
232
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~26 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Nursing facility visit, established patient, straightforward
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes.
276 $26 $41
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
81 $10 $25
Influenza virus detection test
A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation.
44 $16 $25
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
40 $2 $15
SARS-CoV-2 immunoassay test
A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus.
25 $35 $50
Urine microalbumin test
A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function.
18 $6 $15
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
18 $2 $2
Strep A rapid test
A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation.
13 $16 $17
Initial nursing facility care, moderate complexity
Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes.
12 $101 $129
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,648
Total received (2018-2024)
Avg $521/year across 7 years
Top 19% in GA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
219
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,648 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$248
2023
$442
2022
$574
2021
$714
2020
$451
2019
$510
2018
$709

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$59
AstraZeneca Pharmaceuticals LP
$45
Otsuka America Pharmaceutical, Inc.
$42
Exact Sciences Corporation
$35
GlaxoSmithKline, LLC.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Amgen Inc.
$16
Lilly USA, LLC
$15
Top 3 companies account for 59.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$714
GlaxoSmithKline, LLC.
$536
Boehringer Ingelheim Pharmaceuticals, Inc.
$488
Lilly USA, LLC
$458
AstraZeneca Pharmaceuticals LP
$386
Novartis Pharmaceuticals Corporation
$226
SANOFI-AVENTIS U.S. LLC
$159
Esperion Therapeutics, Inc.
$81
Exact Sciences Corporation
$69
Merck Sharp & Dohme Corporation
$51
Amgen Inc.
$48
Allergan Inc.
$44
ABBVIE INC.
$44
Abbott Laboratories
$43
Otsuka America Pharmaceutical, Inc.
$42
Biogen, Inc.
$39
Biohaven Pharmaceuticals, Inc.
$28
Genentech USA, Inc.
$28
AbbVie Inc.
$27
Kowa Pharmaceuticals America, Inc.
$22
Melinta Therapeutics, Inc.
$21
ITI, Inc.
$18
Alexion Pharmaceuticals, Inc.
$18
Astellas Pharma US Inc
$17
Endo Pharmaceuticals Inc.
$16
Avanir Pharmaceuticals, Inc.
$15
West-Ward Pharmaceuticals
$11
Top 3 companies account for 47.6% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · ANORO ELLIPTA · Aimovig · BASAGLAR · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CAPLYTA · Cologuard Collection Kit · EMGALITY · ENTRESTO · FARXIGA · FREESTYLE LIBRE 2 · HUMALOG · JANUVIA · JARDIANCE · LEQVIO · LINZESS · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · NASCOBAL · NEXLETOL · NUEDEXTA · NURTEC ODT · Orbactiv · Otezla · Ozempic · PNEUMOVAX 23 · QULIPTA · REXULTI · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Strensiq · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · VIBERZI · Victoza · Wegovy · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Oglethorpe?
Compare family medicine physicians in the Oglethorpe area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
23
Per 100K population
192.4
County median income
$37,177
Nearest hospital
FLINT RIVER COMMUNITY HOSPITAL
9.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Inhulsen is a remote monitoring specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Inhulsen experienced with nursing facility visit, established patient, straightforward?
Based on Medicare claims data, Dr. Inhulsen performed 276 nursing facility visit, established patient, straightforward services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Inhulsen receive payments from pharmaceutical companies?
Yes. Dr. Inhulsen received a total of $3,648 from 27 companies across 219 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Inhulsen's costs compare to other family medicine physicians in Oglethorpe?
Dr. Inhulsen's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Inhulsen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →